2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma.
Barata P, Tangen C, Plets M, Thompson I, Narayan V, George D, Heng D, Shuch B, Stein M, Gulati S, Tretiakova M, Tripathi A, Bjarnason G, Humphrey P, Adeniran A, Vaishampayan U, Alva A, Zhang T, Cole S, Lara P, Lerner S, Balzer-Haas N, Pal S. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma. Journal Of Clinical Oncology 2024, jco2400767. PMID: 39255440, DOI: 10.1200/jco.24.00767.Peer-Reviewed Original ResearchAdvanced papillary renal cell carcinomaPapillary renal cell carcinomaRenal cell carcinomaOverall survivalCell carcinomaProlonged progression-free survivalLack of survival benefitProgression-free survivalRandomized phase IIMedian follow-upPrimary end pointOpen-label trialOverall survival analysisCrizotinib armMedian OSSurvival benefitClinical trial updateNo significant differenceCabozantinibTreatment armsSunitinibFollow-upClinical trialsSavolitinibCrizotinib
1999
Improved instrumentation to facilitate laparoscopic ureteroureterostomy
Brewer A, McDougall E, Elbahnasy A, Shalhav A, Maxwell K, Kovacs G, Hoenig D, Humphrey P, Clayman R. Improved instrumentation to facilitate laparoscopic ureteroureterostomy. Minimally Invasive Therapy & Allied Technologies 1999, 8: 19-24. DOI: 10.3109/13645709909153127.Peer-Reviewed Original ResearchVascular closure staplesLaparoscopic ureteroureterostomyGroup BGroup AVCS clipsHealing scoresDifferential creatinine clearanceHistological healing scoresReconstructive laparoscopic surgeryEnd ureteroureterostomyCreatinine clearanceOperative timeUreteral transectionRetrograde pyelographyBone metaplasiaClinical trialsLaparoscopic surgeryUreteral diameterClip placementMinimal fibrosisLower poleUreteroureterostomyUreteral stentsOperating timeWeeks